The HeartMate 3 is considered the safest mechanical heart pump of its kind, but a federal database contains more than 4,500 reports in which it may have caused or contributed to a patient's death.

Thoratec devices tied to warning . Thoratec's warning applies to the HeartMate II Pocket System Controller (model No. 105109). It also applies to products with these device catalog numbers ...

ABBOTT PARK, Ill., Aug. 29, 2022/ PRNewswire/-- Abbott today announced new late-breaking data that show its HeartMate 3™ heart pump extends survival of advanced heart failure patients by at ...

Monday's alert is the second Class 1 recall of a HeartMate device this year. In January, Abbott issued an urgent "correction letter" to hospitals about a separate issue in which the HeartMate 3 ...

ABBOTT PARK, Ill., Aug. 28, 2017 /PRNewswire/ -- Abbott (NYSE: ABT) announced today it has received U.S. Food and Drug Administration (FDA) approval for its Full MagLev™ HeartMate 3 ™ Left ...

Thoratec Corp. on Wednesday won U.S. approval to sell an implantable heart device as a permanent treatment for patients too sick for transplants, opening a new market for the product.

Abbott has launched a “first-of-its-kind” trial to identify advanced heart failure patients who could potentially benefit from early advanced therapy options, namely HeartMate 3 left ...

Thoratec Corp. issued a safety advisory regarding its HeartMate II LVAS Pocket System Controller while the company updates related labeling and training materials.

(RTTNews) - Abbott (ABT) said the data from the MOMENTUM 3 trial showed its HeartMate 3 heart pump extended survival of advanced heart failure patients by at least five years. Results of the five ...

The study also found that the HeartMate 3 had an improved survival rate of 58%, compared to 44% with HeartMate II. Further, the device reduced morbidity and mortality compared to HeartMate II.

The company announced plans last week to buy HeartMate's ­manufacturer, Thoratec Corp., in a $3.4 billion deal that would be St. Jude's biggest corporate acquisition ever.